An interventional study of Blood Flow Restriction band in Strength, Range of Motion and Pain-Knee, sponsored by Abasyn University Peshawar. Completed at 1 site in Pakistan. Per ClinicalTrials.gov, last updated 2025-08-15.
Sponsored by Abasyn University Peshawar · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The main objective/s of the study is to compare the effectiveness of low load blood flow restriction training (LL-BFR) with traditional resistance training exercises (T-RT) at improving skeletal muscle hypertrophy, strength, Range of motion (ROM), pain and effusion in individuals who have undergone anterior cruciate ligament (ACL) reconstruction surgery.
The study involves 32 participants who meet the inclusion criteria and randomly assign to either BFR-RT group or the T-RT group. The primary outcomes measured includes skeletal muscle hypertrophy, strength, range of motion, pain, and effusion.
The intervention last for eight weeks, during which participants undergone resistance training according to their assigned group. Data collected at various time points, including post-surgery, mid-training, and post-training, to assess the effectiveness of the two training methods. The findings from this study are effective for anterior cruciate ligament reconstruction surgery (ACLR) patients in early rehabilitation and improve outcomes for individuals recovering from ACL injuries.
The purpose of this randomized controlled trial is to compare the effectiveness of low-load blood flow restriction training (BFR-RT) with low-load traditional resistance training exercises (T-RT) in individuals who have undergone anterior cruciate ligament reconstruction (ACLR) surgery. The anterior cruciate ligament is a major knee ligament that provides stability to the knee joint. ACL injuries are common, and surgical reconstruction is often necessary to restore knee stability and function.
The study was conducted at Rehman Medical Institute over approximately one and a half years. The sample size consists of 32 participants who meet the inclusion criteria, including having undergone unilateral ACLR surgery within the past 8 weeks and being free of any neurological impairments or significant cardiac, pulmonary, or metabolic conditions.
Participants were randomly assigned to either the BFR-RT or T-RT group using a random sampling technique. Randomization was conducted by an independent member of the research team using opaque envelopes containing coded group assignments to ensure unbiased allocation.
The intervention involved 8 weeks of biweekly unilateral leg training on the affected limb under the instruction of a physiotherapist, totaling 16 training sessions. Participants in both groups received the standard rehabilitation program provided by the hospital. In the BFR-RT group, blood flow restriction was achieved using an occlusion band placed on the most proximal portion of the affected limb. The physical therapist ensured the band was not too tight, allowing one finger to pass through the band.
Data were collected at three time points: post-surgery (week 0-1), mid-training (week 4-5), and post-training (week 9). Outcomes measured included skeletal muscle hypertrophy, strength (assessed using manual muscle testing), range of motion (ROM) of the knee joint, pain (assessed using a Knee Injury and Osteoarthritis Outcome Score), and effusion (measured by knee joint circumference). Adherence rates, exercise session attendance, and no adverse events were recorded.
This is the only study on the registry with Abasyn University Peshawar as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Group 1, comprising 16 patients (Group 1), undergo the standard Anterior Cruciate Ligament (ACL) rehabilitation protocol with Blood Flow Restriction (BFR) for 8 weeks during their physiotherapy sessions at the Rehman Medical Institute's Outpatient Department (OPD), starting from the second post-operative visit. The cuff size determined based on the patient's thigh circumference. The rehabilitation protocol will progress as follows: * Week 2-4: Long Arc Quadriceps (LAQ) exercise progression, Shuttle exercise progression, and Post-op visit 2. * Week 4-8: Available range LAQ, Standing terminal knee extension, and Single Limb Shuttle/Leg Press exercises.
Device: Blood Flow Restriction band
Group B, comprising 16 patients (Group 2), undergo the standard Anterior Cruciate Ligament (ACL) rehabilitation protocol without Blood Flow Restriction (BFR) for 8 weeks during their physiotherapy sessions at the Rehman Medical Institute's Outpatient Department (OPD), starting from the second post-operative visit. The cuff size determined based on the patient's thigh circumference. The rehabilitation protocol will progress as follows: * Week 2-4: Long Arc Quadriceps (LAQ) exercise progression, Shuttle exercise progression, and Post-op visit 2. * Week 4-8: Available range LAQ, Standing terminal knee extension, and Single Limb Shuttle/Leg Press exercises.
Device: Blood Flow Restriction band
Blood Flow Restriction (BFR) band operate by partially occluding arterial blood flow to distal structures, but more significantly impeding venous outflow from under the cuff, thereby also hindering venous return. The compression of vasculature proximal to the skeletal muscle leads to inadequate oxygen supply (hypoxia) within the muscle tissue, resulting in a localized hypoxic environment. Additionally, the reduction in venous blood flow causes blood to accumulate in the capillaries of the occluded limb, often manifesting as visible erythema. This temporary restriction will be maintained for a duration of 8 weeks.
Also known as: Brand name: Fitbiz Exercise Equipment
Range of Motion
Knee range of motion assessed weekly for eight consecutive weeks with the patient in a supine position using goniometer.
Time frame: eight weeks
Quadricep Strength
Strength assessed through manual muscle testing (MMT). The grading scale ranges from 0 to 5, with Grade 0 indicating no visible or palpable muscle contraction and Grade 5 indicates muscle movement against gravity and maximal resistance.
Time frame: eight weeks
Knee Pain
Pain was assessed using visual analogue scale. This questionnaire ranges 0 to 10, where 10 indicates the worst pain and 0 indicates no pain. A higher score reflects higher pain.
Time frame: eight weeks
Quadricep Size
Muscle size assessed using measuring tap wrapping around the thigh of pre-patellar region.
Time frame: eight weeks
Medical hospital
| Milestone | Non-Blood Flow Restriction Band | Blood Flow Restriction Band |
|---|---|---|
| Started | 16 | 16 |
| Completed | 16 | 16 |
| Not completed | 0 | 0 |
Knee range of motion assessed weekly for eight consecutive weeks with the patient in a supine position using goniometer.
| Degrees | Blood Flow Restriction Band | Non-Blood Flow Restriction Band |
|---|---|---|
| Range of Motion | 74.0625 ± 14.04976 | 80.3125 ± 14.65933 |
Strength assessed through manual muscle testing (MMT). The grading scale ranges from 0 to 5, with Grade 0 indicating no visible or palpable muscle contraction and Grade 5 indicates muscle movement against gravity and maximal resistance.
| units on a scale | Blood Flow Restriction Band | Non-Blood Flow Restriction Band |
|---|---|---|
| Quadricep Strength | 3.9375 ± 3.5 | .6800735 ± .5163978 |
Pain was assessed using visual analogue scale. This questionnaire ranges 0 to 10, where 10 indicates the worst pain and 0 indicates no pain. A higher score reflects higher pain.
| units on a scale | Blood Flow Restriction Band | Non-Blood Flow Restriction Band |
|---|---|---|
| Knee Pain | 2.0625 ± 1.12361 | 1.9375 ± 1.340087 |
Muscle size assessed using measuring tap wrapping around the thigh of pre-patellar region.
| cm | Blood Flow Restriction Band | Non-Blood Flow Restriction Band |
|---|---|---|
| Quadricep Size | 19.375 ± 2.028957 | 18.65625 ± 2.650275 |
Collected over Adverse effects were not assessed.. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Blood Flow Restriction Band | — | — | — |
| Non-Blood Flow Restriction Band | — | — | — |
Data were analyzed by checking the normality of data. Sample T test and Mann Whitney U test were used for two groups
| Age, Categorical(Participants) | Non-Blood Flow Restriction Band | Blood Flow Restriction Band | Total |
|---|---|---|---|
| <=18 years | 0 | 0 | 0 |
| Between 18 and 65 years | 16 | 16 | 32 |
| >=65 years | 0 | 0 | 0 |
| Sex: Female, Male(Participants) | Non-Blood Flow Restriction Band | Blood Flow Restriction Band | Total |
|---|---|---|---|
| Female | 5 | 2 | 7 |
| Male | 11 | 14 | 25 |
| Race and Ethnicity Not Collected(Participants) | Non-Blood Flow Restriction Band | Blood Flow Restriction Band | Total |
|---|---|---|---|
| Count of participants | — | — | 0 |
| Region of Enrollment(Participants) | Non-Blood Flow Restriction Band | Blood Flow Restriction Band | Total |
|---|---|---|---|
| Pakistan | 16 | 16 | 32 |
| Region of Enrollment(participants) | Non-Blood Flow Restriction Band | Blood Flow Restriction Band | Total |
|---|---|---|---|
| Pakistan | 16 | 16 | 32 |
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: Yes — IPD will be share during and after the study completion with other researchers.
Supporting information: Study protocol, Statistical analysis plan
Time frame: Within a 1-year timeframe, the study will share all required documents and SAPs with other researchers.
Access criteria: PDF
Ran from Jun 2023 to primary completion in Jun 2024, 12 months.
Results were first posted in Aug 2025, 1 year 1 month after primary completion.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hydrarthrosis